ArticleFrontiers in immunology2026

Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study.

Yuhao Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.